![Lisa Borland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Borland is the founder of Xoc Pharmaceuticals, Inc. Former job includes Head-Media & Investor Relations at MAP Pharmaceuticals LLC in 2012.
| Companies | Position | End |
|---|---|---|
Xoc Pharmaceuticals, Inc.
 Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Founder | 2019-11-30 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Public Communications Contact | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
Xoc Pharmaceuticals, Inc.
Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel oral therapies for migraine prevention and dopamine agonism parkinson’s disease management | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
